Expression of Indoleamine 2,3-Dioxygenase in Metastatic Pancreatic Ductal Adenocarcinoma Recruits Regulatory T Cells to Avoid Immune Detection

Journal of the American College of Surgeons

Volumn 206, Issue 5, 2008, Pages 849-854

  Witkiewicz, Agnes ^a   Williams, Timothy K ^a   Cozzitorto, Joseph ^a   Durkan, Brandice ^a   Showalter, Shayna L ^a   Yeo, Charles J ^a   Brody, Jonathan R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; PROTEIN HYDROLYSATE; TRANSCRIPTION FACTOR FOXP3; TRYPTOPHAN;

ARTICLE; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TUMOR CELL; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING;

ADENOCARCINOMA; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LYMPH NODES; PANCREATIC NEOPLASMS; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 43049103779     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.12.014     Document Type: Article

References (19)

1. Winter J.M., Cameron J.L., Campbell K.A., et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10 (2006) 1199-1211
2. Hruban R.H., Iacobuzio-Donahue C., Wilentz R.E., et al. Molecular pathology of pancreatic cancer. Cancer J 7 (2001) 251-258
3. Munn D.H., and Mellor A.L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117 (2007) 1147-1154
4. Uyttenhove C., Pilotte L., Theate I., et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9 (2003) 1269-1274
5. Munn D.H., Zhou M., Attwood J.T., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 5380 (1998) 1191-1193
6. Fallarino F., Grohmann U., You S., et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176 (2006) 6752-6761
7. Colombo M.P., and Piconese S. Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy. Nat Rev Cancer 7 (2007) 880-887
8. Curti A., Pandolfi S., Valzasina B., et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood 109 (2007) 2871-2887
9. Brandacher G., Perathoner A., Ladurner R., et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 12 (2006) 1144-1151
10. Laheru D., and Jaffee E.M. Immunotherapy for pancreatic cancer-science driving clinical progress. Nat Rev Cancer 5 (2005) 459-467
11. Jaffee E.M., Hruban R.H., Biedrzycki B., et al. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol 19 (2001) 145-156
12. Yasui H., Takai K., Yoshida R., and Hayaishi O. Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: Its possible occurrence in cancer patients. Proc Natl Acad Sci U S A 83 (1986) 6622-6626
13. Zheng Y., and Rudensky A.Y. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8 (2007) 457-462
14. Pfefferkorn E.R. Interferon gamma blocks the growth of toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A 81 (1984) 908-912
15. Ino K., Yoshida N., Kajiyama H., et al. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer. Br J Cancer 95 (2006) 1555-1561
16. Nakamura T., Shima T., Saeki A., et al. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci 98 (2007) 874-881
17. Polak M.E., Borthwick N.J., Gabriel F.G., et al. Mechanisms of local immunosuppression in cutaneous melanoma. Br J Cancer 96 (2007) 1879-1887
18. Muller A.J., and Prendergast G.C. Indoleamine 2,3-dioxygenase in immune suppression and cancer. Curr Cancer Drug Targets 7 (2007) 31-40
19. Mellor A.L., Baban B., Chandler P., et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 171 (2003) 1652-1655